Fresh Tracks Therapeutics, Inc. (FRTX)
OTCMKTS
· Delayed Price · Currency is USD
0.930
0.00 (0.00%)
Jan 29, 2025, 4:00 PM EST
Fresh Tracks Therapeutics Revenue
In the year 2023, Fresh Tracks Therapeutics had annual revenue of $8.01M with 15.31% growth.
Revenue
8.01M
Revenue Growth
+15.31%
P/S Ratio
0.63
Revenue / Employee
2.00M
Employees
4
Market Cap
5.56M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| Veradigm | 1.53B |
| SS Innovations International | 16.04M |
| Elite Pharmaceuticals | 71.17M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 21.77M |
| SANUWAVE Health | 29.30M |
Fresh Tracks Therapeutics News
- 2 days ago - Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution - PRNewsWire
- 7 weeks ago - Fresh Tracks Therapeutics Announces Hearing Date and Notice of Proposed Consent Judgement Regarding Dissolution of Company - PRNewsWire
- 8 months ago - Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company - GlobeNewsWire
- 1 year ago - Fresh Tracks Therapeutics Urges Stockholders to Vote at the Upcoming Special Meeting on February 15th - GlobeNewsWire
- 1 year ago - Fresh Tracks Therapeutics Announces Plan to Hold New Special Meeting of Stockholders on February 15th - GlobeNewsWire
- 1 year ago - Fresh Tracks Therapeutics Announces Listing on OTC Pink Market - GlobeNewsWire
- 1 year ago - Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th - GlobeNewsWire
- 1 year ago - Fresh Tracks Therapeutics Announces Third Adjournment of Special Meeting of Stockholders - GlobeNewsWire